id	sid	eid	entity	type
dpc-2824	2	1	1	CARDINAL
dpc-2824	2	2	indian	NORP
dpc-2824	2	3	varghese panicker1	PERSON
dpc-2824	2	4	wesley mannirathil	PERSON
dpc-2824	2	5	jose2 1	ORG
dpc-2824	2	6	amrita institute of medical sciences	ORG
dpc-2824	2	7	kochi	GPE
dpc-2824	2	8	india	GPE
dpc-2824	2	9	2	CARDINAL
dpc-2824	2	10	amrita institute of medical sciences	ORG
dpc-2824	2	11	kochi	GPE
dpc-2824	2	12	india	GPE
dpc-2824	2	13	jose wm	PERSON
dpc-2824	2	14	indian	NORP
dpc-2824	5	1	https://doi.org/10.5826/	ORG
dpc-2824	5	2	december 15	DATE
dpc-2824	5	3	2022	CARDINAL
dpc-2824	6	1	july 2023	DATE
dpc-2824	6	2	2023	CARDINAL
dpc-2824	7	1	https://creativecommons.org/licenses/by-nc/4.0/	ORG
dpc-2824	11	1	amrita institute of medical sciences	ORG
dpc-2824	12	1	0484-2858590	DATE
dpc-2824	12	2	9847179964	DATE
dpc-2824	12	3	indian	NORP
dpc-2824	13	1	iraes	GPE
dpc-2824	14	1	indian	NORP
dpc-2824	15	1	86	CARDINAL
dpc-2824	15	2	india	GPE
dpc-2824	16	1	eighty-six	CARDINAL
dpc-2824	16	2	16	CARDINAL
dpc-2824	16	3	18.6%	PERCENT
dpc-2824	16	4	12.8%	PERCENT
dpc-2824	16	5	8.1%	PERCENT
dpc-2824	17	1	kaplan	PERSON
dpc-2824	17	2	meier	PERSON
dpc-2824	17	3	0.023	CARDINAL
dpc-2824	17	4	50%	PERCENT
dpc-2824	17	5	18.5%	PERCENT
dpc-2824	17	6	0.008	CARDINAL
dpc-2824	18	1	2	CARDINAL
dpc-2824	19	1	1	CARDINAL
dpc-2824	19	2	1	CARDINAL
dpc-2824	19	3	4	CARDINAL
dpc-2824	19	4	1	CARDINAL
dpc-2824	23	1	iraes	PERSON
dpc-2824	24	1	one	CARDINAL
dpc-2824	25	1	2	CARDINAL
dpc-2824	26	1	iraes	NORP
dpc-2824	26	2	iraes	NORP
dpc-2824	27	1	3–6	CARDINAL
dpc-2824	28	1	indian	NORP
dpc-2824	29	1	hispanics	NORP
dpc-2824	29	2	caucasian	NORP
dpc-2824	32	1	indian	NORP
dpc-2824	33	1	indian	NORP
dpc-2824	34	1	pembrolizumab	PERSON
dpc-2824	34	2	atezolizumab	PERSON
dpc-2824	34	3	january 2017 to september 2021	DATE
dpc-2824	35	1	the hospital institution review board	ORG
dpc-2824	36	1	at least one	CARDINAL
dpc-2824	36	2	pembrolizumab	PERSON
dpc-2824	36	3	pd-l1	GPE
dpc-2824	40	1	1.1	CARDINAL
dpc-2824	40	2	1.0	CARDINAL
dpc-2824	41	1	5.0	CARDINAL
dpc-2824	42	1	one	CARDINAL
dpc-2824	42	2	two	CARDINAL
dpc-2824	42	3	0	CARDINAL
dpc-2824	43	1	october 2021	DATE
dpc-2824	48	1	indian	NORP
dpc-2824	48	2	caucasian	NORP
dpc-2824	52	1	first	ORDINAL
dpc-2824	53	1	1.1	CARDINAL
dpc-2824	53	2	1.0	CARDINAL
dpc-2824	56	1	ibm	ORG
dpc-2824	56	2	20.0	CARDINAL
dpc-2824	56	3	spss inc,	ORG
dpc-2824	56	4	chicago	GPE
dpc-2824	58	1	±	CARDINAL
dpc-2824	59	1	chi-square	PERSON
dpc-2824	60	1	kaplan	ORG
dpc-2824	62	1	0.05	CARDINAL
dpc-2824	63	1	86	CARDINAL
dpc-2824	63	2	age 60.5 years	DATE
dpc-2824	63	3	83	DATE
dpc-2824	64	1	26	CARDINAL
dpc-2824	64	2	30.2%	PERCENT
dpc-2824	65	1	12	CARDINAL
dpc-2824	65	2	13.9%	PERCENT
dpc-2824	65	3	10	CARDINAL
dpc-2824	65	4	11.6%	PERCENT
dpc-2824	65	5	10	CARDINAL
dpc-2824	65	6	11.6%	PERCENT
dpc-2824	66	1	three months	DATE
dpc-2824	66	2	five	CARDINAL
dpc-2824	66	3	3-8.75	CARDINAL
dpc-2824	67	1	fifty-one	CARDINAL
dpc-2824	67	2	59.3%	PERCENT
dpc-2824	67	3	29	CARDINAL
dpc-2824	67	4	33.7%	PERCENT
dpc-2824	67	5	pembrolizumab	PERSON
dpc-2824	67	6	five	CARDINAL
dpc-2824	67	7	5.8%	PERCENT
dpc-2824	67	8	one	CARDINAL
dpc-2824	67	9	1.2%	PERCENT
dpc-2824	68	1	1	CARDINAL
dpc-2824	69	1	42	CARDINAL
dpc-2824	69	2	28	CARDINAL
dpc-2824	69	3	32.5%	PERCENT
dpc-2824	69	4	six	CARDINAL
dpc-2824	69	5	6.97%	PERCENT
dpc-2824	69	6	more than one	CARDINAL
dpc-2824	70	1	18.6%	PERCENT
dpc-2824	70	2	1	CARDINAL
dpc-2824	72	1	n (%	PERCENT
dpc-2824	72	2	60.5	CARDINAL
dpc-2824	72	3	iqr:48	GPE
dpc-2824	72	4	64	DATE
dpc-2824	72	5	74.4%	PERCENT
dpc-2824	72	6	26	CARDINAL
dpc-2824	72	7	30.2%	PERCENT
dpc-2824	72	8	12	CARDINAL
dpc-2824	72	9	13.9%	PERCENT
dpc-2824	72	10	10	CARDINAL
dpc-2824	72	11	11.6%	PERCENT
dpc-2824	72	12	11.6%	PERCENT
dpc-2824	72	13	8 (9.3%	PERCENT
dpc-2824	72	14	7	DATE
dpc-2824	72	15	8.1%	PERCENT
dpc-2824	72	16	3 (3.5%	PERCENT
dpc-2824	72	17	2	CARDINAL
dpc-2824	72	18	2.3%	PERCENT
dpc-2824	72	19	2	CARDINAL
dpc-2824	72	20	2.3%	PERCENT
dpc-2824	72	21	6 (	PERCENT
dpc-2824	72	22	7.2%	PERCENT
dpc-2824	72	23	51	DATE
dpc-2824	72	24	59.3%	PERCENT
dpc-2824	72	25	33.7%	PERCENT
dpc-2824	72	26	5 (	PERCENT
dpc-2824	72	27	5.8%	PERCENT
dpc-2824	72	28	+ ipilimumab	GPE
dpc-2824	72	29	1 (1.2%	PERCENT
dpc-2824	72	30	1 13	CARDINAL
dpc-2824	72	31	15.1%	PERCENT
dpc-2824	72	32	2 20	CARDINAL
dpc-2824	72	33	23.2%	PERCENT
dpc-2824	72	34	3 8	DATE
dpc-2824	72	35	9.3%	PERCENT
dpc-2824	72	36	4 1	DATE
dpc-2824	72	37	1.2%	PERCENT
dpc-2824	72	38	1	CARDINAL
dpc-2824	72	39	1.2%	PERCENT
dpc-2824	74	1	15.1%	PERCENT
dpc-2824	75	1	two months	DATE
dpc-2824	76	1	2	CARDINAL
dpc-2824	76	2	twenty-four	CARDINAL
dpc-2824	76	3	16	CARDINAL
dpc-2824	76	4	18.6%	PERCENT
dpc-2824	76	5	11	CARDINAL
dpc-2824	76	6	12.8%	PERCENT
dpc-2824	76	7	4	CARDINAL
dpc-2824	76	8	7	CARDINAL
dpc-2824	76	9	2	CARDINAL
dpc-2824	77	1	irae	ORG
dpc-2824	77	2	1	CARDINAL
dpc-2824	77	3	2	CARDINAL
dpc-2824	77	4	3	CARDINAL
dpc-2824	77	5	4	CARDINAL
dpc-2824	77	6	9	CARDINAL
dpc-2824	77	7	24	CARDINAL
dpc-2824	77	8	1 11	DATE
dpc-2824	77	9	13	CARDINAL
dpc-2824	77	10	1	CARDINAL
dpc-2824	77	11	1	CARDINAL
dpc-2824	77	12	2	CARDINAL
dpc-2824	77	13	1	CARDINAL
dpc-2824	77	14	1	CARDINAL
dpc-2824	77	15	0	CARDINAL
dpc-2824	77	16	1	CARDINAL
dpc-2824	78	1	one month	DATE
dpc-2824	79	1	one	CARDINAL
dpc-2824	79	2	two weeks	DATE
dpc-2824	79	3	four weeks	DATE
dpc-2824	80	1	15	CARDINAL
dpc-2824	80	2	12	CARDINAL
dpc-2824	80	3	one	CARDINAL
dpc-2824	80	4	two	CARDINAL
dpc-2824	81	1	6 months	DATE
dpc-2824	81	2	3 months	DATE
dpc-2824	81	3	0.016	CARDINAL
dpc-2824	81	4	15 months	DATE
dpc-2824	81	5	8 months	DATE
dpc-2824	81	6	0.03	CARDINAL
dpc-2824	82	1	orr	PERSON
dpc-2824	82	2	39.2%	PERCENT
dpc-2824	82	3	17.2%	PERCENT
dpc-2824	82	4	0.02	CARDINAL
dpc-2824	83	1	kaplan-meier	PERSON
dpc-2824	83	2	1	CARDINAL
dpc-2824	84	1	8 months	DATE
dpc-2824	84	2	3 months	DATE
dpc-2824	84	3	0.023	CARDINAL
dpc-2824	84	4	orr	PERSON
dpc-2824	84	5	50%	PERCENT
dpc-2824	84	6	18.5%	PERCENT
dpc-2824	84	7	0.008	CARDINAL
dpc-2824	84	8	aes	ORG
dpc-2824	85	1	15 months	DATE
dpc-2824	85	2	10 months	DATE
dpc-2824	86	1	0.246	CARDINAL
dpc-2824	87	1	kaplan-meier	PERSON
dpc-2824	87	2	2	CARDINAL
dpc-2824	87	3	7	DATE
dpc-2824	87	4	8.1%	PERCENT
dpc-2824	87	5	2	CARDINAL
dpc-2824	87	6	2.3%	PERCENT
dpc-2824	87	7	one	CARDINAL
dpc-2824	87	8	1.2%	PERCENT
dpc-2824	89	1	9	CARDINAL
dpc-2824	89	2	1	CARDINAL
dpc-2824	89	3	37.5%	PERCENT
dpc-2824	89	4	9	CARDINAL
dpc-2824	89	5	2	CARDINAL
dpc-2824	89	6	37.5%	PERCENT
dpc-2824	89	7	6	CARDINAL
dpc-2824	89	8	3	CARDINAL
dpc-2824	89	9	25%	PERCENT
dpc-2824	90	1	4	CARDINAL
dpc-2824	91	1	3	CARDINAL
dpc-2824	91	2	16	CARDINAL
dpc-2824	91	3	ten	CARDINAL
dpc-2824	91	4	62.5%	PERCENT
dpc-2824	91	5	five	CARDINAL
dpc-2824	91	6	31.25%	PERCENT
dpc-2824	91	7	pembrolizumab	PERSON
dpc-2824	91	8	one	CARDINAL
dpc-2824	91	9	6.25%	PERCENT
dpc-2824	92	1	ciraes	PERSON
dpc-2824	92	2	2.75 months	DATE
dpc-2824	92	3	4	CARDINAL
dpc-2824	92	4	3-6	CARDINAL
dpc-2824	93	1	16	CARDINAL
dpc-2824	93	2	11	DATE
dpc-2824	93	3	68.75%	PERCENT
dpc-2824	94	1	four	CARDINAL
dpc-2824	95	1	four	CARDINAL
dpc-2824	95	2	25%	PERCENT
dpc-2824	95	3	3	CARDINAL
dpc-2824	95	4	2	CARDINAL
dpc-2824	95	5	1	CARDINAL
dpc-2824	95	6	1	CARDINAL
dpc-2824	96	1	4	CARDINAL
dpc-2824	97	1	3	CARDINAL
dpc-2824	99	1	1	CARDINAL
dpc-2824	99	2	2	CARDINAL
dpc-2824	99	3	3	CARDINAL
dpc-2824	99	4	4 16	CARDINAL
dpc-2824	99	5	18.6%	PERCENT
dpc-2824	99	6	24	CARDINAL
dpc-2824	99	7	5	CARDINAL
dpc-2824	99	8	3	CARDINAL
dpc-2824	99	9	1 1	CARDINAL
dpc-2824	99	10	0	CARDINAL
dpc-2824	99	11	0 1	CARDINAL
dpc-2824	99	12	0	CARDINAL
dpc-2824	99	13	0	CARDINAL
dpc-2824	99	14	1	CARDINAL
dpc-2824	99	15	0	CARDINAL
dpc-2824	99	16	0	CARDINAL
dpc-2824	99	17	1	CARDINAL
dpc-2824	100	1	kaplan meier	PERSON
dpc-2824	102	1	5	CARDINAL
dpc-2824	103	1	lichenoid eruption	ORG
dpc-2824	103	2	acneiform eruptions	PERSON
dpc-2824	104	1	17	CARDINAL
dpc-2824	105	1	2.75 months	DATE
dpc-2824	105	2	2 months	DATE
dpc-2824	106	1	18	CARDINAL
dpc-2824	107	1	six	CARDINAL
dpc-2824	107	2	only two	CARDINAL
dpc-2824	107	3	four	CARDINAL
dpc-2824	110	1	1	CARDINAL
dpc-2824	110	2	2	CARDINAL
dpc-2824	110	3	75 %	PERCENT
dpc-2824	111	1	4	CARDINAL
dpc-2824	112	1	15	CARDINAL
dpc-2824	112	2	14	DATE
dpc-2824	112	3	13	CARDINAL
dpc-2824	112	4	two	CARDINAL
dpc-2824	112	5	0	CARDINAL
dpc-2824	113	1	one	CARDINAL
dpc-2824	114	1	two	CARDINAL
dpc-2824	115	1	1	CARDINAL
dpc-2824	115	2	2	CARDINAL
dpc-2824	116	1	one	CARDINAL
dpc-2824	117	1	orr	PERSON
dpc-2824	118	1	3,19	CARDINAL
dpc-2824	119	1	0.558	CARDINAL
dpc-2824	119	2	0.033	CARDINAL
dpc-2824	119	3	0.698	CARDINAL
dpc-2824	119	4	0.046	TIME
dpc-2824	120	1	irae	GPE
dpc-2824	120	2	0.453	CARDINAL
dpc-2824	120	3	0.028	CARDINAL
dpc-2824	121	1	indian	NORP
dpc-2824	122	1	indian	NORP
dpc-2824	126	1	up-to 70%	PERCENT
dpc-2824	126	2	11	CARDINAL
dpc-2824	127	1	the united states	GPE
dpc-2824	127	2	25.1%	PERCENT
dpc-2824	127	3	12	CARDINAL
dpc-2824	128	1	taiwanese	NORP
dpc-2824	128	2	27.4%	PERCENT
dpc-2824	129	1	13	CARDINAL
dpc-2824	130	1	18.6%	PERCENT
dpc-2824	131	1	13–15	CARDINAL
dpc-2824	132	1	16	CARDINAL
dpc-2824	133	1	two	CARDINAL
dpc-2824	133	2	2	CARDINAL
dpc-2824	134	1	kaplan meier	PERSON
dpc-2824	135	1	6	CARDINAL
dpc-2824	137	1	doi:10.21037/jtd.2019.08.29	ORG
dpc-2824	138	1	pmid	PERSON
dpc-2824	138	2	32802459	CARDINAL
dpc-2824	141	1	florez ma	PERSON
dpc-2824	141	2	kemnade jo	PERSON
dpc-2824	141	3	chen n	PERSON
dpc-2824	143	1	2022;2022(8):806–813	CARDINAL
dpc-2824	144	1	10.1158/2767-9764.crc-21-0143	DATE
dpc-2824	145	1	35966167	DATE
dpc-2824	147	1	resnick k	PERSON
dpc-2824	147	2	zang p	GPE
dpc-2824	147	3	travis larsen	PERSON
dpc-2824	148	1	j clin oncol	PERSON
dpc-2824	149	1	2022;40:16	PERSON
dpc-2824	150	1	10.1200	CARDINAL
dpc-2824	151	1	peravali m	PERSON
dpc-2824	153	1	j clin	PERSON
dpc-2824	156	1	pmid	PERSON
dpc-2824	156	2	33680877	DATE
dpc-2824	158	1	11	CARDINAL
dpc-2824	159	1	schneider	PERSON
dpc-2824	159	2	naidoo j	PERSON
dpc-2824	159	3	asco guideline	PERSON
dpc-2824	160	1	j clin oncol	PERSON
dpc-2824	161	1	2021;39(36):4073-4126	CARDINAL
dpc-2824	163	1	34724392	DATE
dpc-2824	164	1	12	CARDINAL
dpc-2824	165	1	wongvibulsin s	PERSON
dpc-2824	166	1	united states	GPE
dpc-2824	167	1	j am	PERSON
dpc-2824	168	1	2022;86(3):563-572	CARDINAL
dpc-2824	168	2	doi:10.1016/j.jaad.2021.03.094	ORG
dpc-2824	169	1	33819538	CARDINAL
dpc-2824	171	1	cho yt	PERSON
dpc-2824	171	2	lin yt	PERSON
dpc-2824	171	3	yang cw	PERSON
dpc-2824	171	4	chu cy	PERSON
dpc-2824	171	5	taiwanese	NORP
dpc-2824	172	1	sci rep	ORG
dpc-2824	172	2	2022;12(1):7021	CARDINAL
dpc-2824	173	1	10.1038	CARDINAL
dpc-2824	174	1	35487955	DATE
dpc-2824	176	1	14	CARDINAL
dpc-2824	177	1	phillips gs	PERSON
dpc-2824	178	1	j am	PERSON
dpc-2824	179	1	2020;83(5):1255–1268	CARDINAL
dpc-2824	179	2	doi:10.1016	GPE
dpc-2824	180	1	32454097	DATE
dpc-2824	182	1	15	CARDINAL
dpc-2824	183	1	wang e	PERSON
dpc-2824	183	2	ketosugbo k	PERSON
dpc-2824	183	3	kern ja	PERSON
dpc-2824	183	4	leung dym.	PERSON
dpc-2824	186	1	2021;126(6):613–622	CARDINAL
dpc-2824	186	2	doi:10.1016	GPE
dpc-2824	187	1	33609771	DATE
dpc-2824	189	1	16	CARDINAL
dpc-2824	189	2	larsabal m	PERSON
dpc-2824	189	3	marti	PERSON
dpc-2824	190	1	j am	PERSON
dpc-2824	191	1	2017;76(5):863-870	CARDINAL
dpc-2824	192	1	doi:10.1016	GPE
dpc-2824	192	2	j. jaad.2016.10.044	PERSON
dpc-2824	193	1	pmid	PERSON
dpc-2824	193	2	28094061	TIME
dpc-2824	194	1	17	CARDINAL
dpc-2824	195	1	malviya n	PERSON
dpc-2824	195	2	leventhal j	PERSON
dpc-2824	195	3	alloo a.	PERSON
dpc-2824	196	1	clin	PERSON
dpc-2824	197	1	2020;38(6):660–678	CARDINAL
dpc-2824	197	2	doi:10.1016	GPE
dpc-2824	199	1	pmid	PERSON
dpc-2824	199	2	33341200	DATE
dpc-2824	200	1	18	CARDINAL
dpc-2824	201	1	thompson	PERSON
dpc-2824	201	2	chang ms	PERSON
dpc-2824	203	1	doi:10.1001	GPE
dpc-2824	204	1	33760001	DATE
dpc-2824	206	1	fujii t	GPE
dpc-2824	206	2	colen rr	PERSON
dpc-2824	206	3	bilen ma	PERSON
dpc-2824	206	4	md anderson	PERSON
dpc-2824	212	1	six	CARDINAL
dpc-2824	212	2	16	CARDINAL
dpc-2824	213	1	indian	NORP
dpc-2824	219	1	1	CARDINAL
dpc-2824	219	2	lee l	PERSON
dpc-2824	219	3	gupta m	ORG
dpc-2824	219	4	s. immune	PERSON
dpc-2824	220	1	j clin pharmacol	PERSON
dpc-2824	221	1	2016;56(2):157–169	CARDINAL
dpc-2824	223	1	26183909	DATE
dpc-2824	224	1	2	CARDINAL
dpc-2824	224	2	ramos-casals m	PERSON
dpc-2824	224	3	brahmer jr, callahan mk	PERSON
dpc-2824	225	1	nat rev dis	PERSON
dpc-2824	226	1	2020;6(1):38	CARDINAL
dpc-2824	226	2	doi:10.1038	ORG
dpc-2824	227	1	32382051	DATE
dpc-2824	229	1	3	CARDINAL
dpc-2824	229	2	rogado j	PERSON
dpc-2824	229	3	jm	ORG
dpc-2824	229	4	romero-laorden n	PERSON
dpc-2824	231	1	2019;109:21-27	CARDINAL
dpc-2824	232	1	doi:10.1016/j.ejca.2018.10.014.	FAC
dpc-2824	233	1	30682533	DATE
dpc-2824	234	1	4	CARDINAL
dpc-2824	234	2	thompson	PERSON
dpc-2824	234	3	chang ms	PERSON
dpc-2824	234	4	polyakov nj	PERSON
dpc-2824	236	1	j am	PERSON
dpc-2824	237	1	2022;86(4):886-889	CARDINAL
dpc-2824	239	1	33722547	TIME
dpc-2824	240	1	haratani k	PERSON
dpc-2824	240	2	chiba y	PERSON
dpc-2824	240	3	jama oncol	PERSON
dpc-2824	241	1	2018;4(3):374-378	CARDINAL
dpc-2824	242	1	doi:10.1001	GPE
dpc-2824	243	1	28975219	CARDINAL
dpc-2824	245	1	daud	PERSON
dpc-2824	245	2	pembrolizumab	PERSON
dpc-2824	247	1	2015;151(11):1206-1212	CARDINAL
dpc-2824	248	1	doi:10 .1001	PERSON
dpc-2824	249	1	pmid	PERSON
dpc-2824	249	2	26222619	DATE
dpc-2824	251	1	lee j	PERSON
dpc-2824	251	2	sun jm	PERSON
dpc-2824	251	3	lee	PERSON
dpc-2824	251	4	park k	PERSON
dpc-2824	251	5	ahn mj	PERSON
dpc-2824	252	1	j thorac	PERSON
dpc-2824	254	1	7 21	DATE
dpc-2824	255	1	phillips gs	PERSON
dpc-2824	255	2	wu j	PERSON
dpc-2824	255	3	hellmann md	GPE
dpc-2824	257	1	j clin oncol	PERSON
dpc-2824	260	1	31216228	CARDINAL
dpc-2824	262	1	22	CARDINAL
dpc-2824	263	1	gault	ORG
dpc-2824	263	2	anderson ae	PERSON
dpc-2824	266	1	2021;185(2):263–271	CARDINAL
dpc-2824	267	1	doi:10.1111	ORG
dpc-2824	268	1	pmid	PERSON
dpc-2824	268	2	33393076.original	CARDINAL
dpc-2824	268	3	article 2018;36(4):638–646	LAW
dpc-2824	268	4	10.1007	CARDINAL
dpc-2824	269	1	29159766	DATE
dpc-2824	271	1	20	CARDINAL
dpc-2824	273	1	2021;10:570752	CARDINAL
dpc-2824	273	2	10.3389	CARDINAL
dpc-2824	274	1	pmid	PERSON
dpc-2824	274	2	33520695	DATE